🔴 Niagen Bioscience is trading 6.23% down in pre-market with no clear catalyst identified

Niagen Bioscience is trading 6.23% down at $3.01 after falling from the August 27 close of $3.21, with no clear catalyst identified.

• No credible August 28, 2026 company-specific announcement, filing, earnings release, or analyst action was identified.
• The latest major disclosures were second-quarter results on August 4 and a Walmart.com launch on August 6.
• Broader markets are mixed, with no clear sector or global catalyst explaining the decline.